This inventor holds 1 USPTO granted patent. Top assignees: Albany Molecular Research, Inc., Merck Sharp + Dohme Corp.. Active years: 2012.
Company Filing History:
1 out of 97 
1 out of 2,405 
Years Active: 2012
Title: The Innovations of Michael M -c Lo
Introduction
Michael M -c Lo is an accomplished inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific receptors in the human body. His work has implications for treating various health conditions, including obesity and diabetes.
Latest Patents
Michael M -c Lo holds a patent for "Substituted imidazoles as bombesin receptor subtype-3 modulators." This patent describes certain novel substituted imidazoles that act as ligands for the human bombesin receptor, specifically targeting the bombesin receptor subtype-3 (BRS-3). These compounds are valuable for the treatment, control, or prevention of diseases and disorders that can be managed through the modulation of BRS-3.
Career Highlights
Throughout his career, Michael has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Albany Molecular Research, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.
Collaborations
Michael has collaborated with notable professionals in his field, including David Chen and Christopher L Franklin. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Michael M -c Lo is a notable inventor whose work in pharmaceuticals has the potential to impact the treatment of significant health issues. His innovative approach to receptor modulation showcases the importance of research and development in the medical field.